Cowealth Medical Holding Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,956	4,193	4,813	5,626	5,140
Revenue Growth (YoY)	-29.49%	-12.88%	-14.46%	9.47%	8.85%
Cost of Revenue	2,564	3,401	3,828	4,522	4,082
Gross Profit	392.18	791.52	984.45	1,104	1,058
Selling, General & Admin	555.18	683.78	726.97	701.99	687.62
Research & Development	16.58	16.7	13.96	12.36	-
Operating Expenses	667.6	694.39	720.28	734.62	718.09
Operating Income	-275.42	97.13	264.17	369.83	339.84
Interest Expense	-22.72	-28.92	-34.74	-24.97	-24.39
Interest & Investment Income	20.95	11.28	20.41	37.25	10.58
Earnings From Equity Investments	-1.33	0.64	0.5	0.11	-0.07
Currency Exchange Gain (Loss)	-8.32	0.74	-1.49	-1.37	-1.59
Other Non Operating Income (Expenses)	0.16	4.36	-6.05	5.92	10.38
EBT Excluding Unusual Items	-286.69	85.22	242.79	386.76	334.75
Gain (Loss) on Sale of Investments	1.19	1.82	14.87	-0.14	-
Gain (Loss) on Sale of Assets	-0.01	1.74	0.63	-0.79	-0.02
Other Unusual Items	0.21	0.14	0.01	2.52	-
Pretax Income	-285.3	88.92	258.31	388.34	334.74
Income Tax Expense	45.81	40.93	119.95	153.14	118.82
Earnings From Continuing Operations	-331.11	48	138.36	235.2	215.91
Minority Interest in Earnings	84.55	-47.37	-89.25	-141.08	-76.45
Net Income	-246.56	0.63	49.11	94.12	139.46
Net Income to Common	-246.56	0.63	49.11	94.12	139.46
Net Income Growth	-	-98.72%	-47.82%	-32.52%	12.12%
Shares Outstanding (Basic)	77	77	77	77	77
Shares Outstanding (Diluted)	77	77	77	77	78
Shares Change (YoY)	-	-0.03%	-0.02%	-0.02%	0.02%
EPS (Basic)	-3.18	0.01	0.63	1.22	1.80
EPS (Diluted)	-3.18	0.01	0.63	1.21	1.80
EPS Growth	-	-98.71%	-47.93%	-32.78%	12.07%
Free Cash Flow	6.46	411.98	-161.34	-286.27	-152.91
Free Cash Flow Per Share	0.08	5.32	-2.08	-3.69	-1.97
Dividend Per Share	-	-	0.400	1.600	1.500
Dividend Growth	-	-	-75.00%	6.67%	25.00%
Gross Margin	13.27%	18.88%	20.46%	19.63%	20.58%
Operating Margin	-9.32%	2.32%	5.49%	6.57%	6.61%
Profit Margin	-8.34%	0.01%	1.02%	1.67%	2.71%
Free Cash Flow Margin	0.22%	9.83%	-3.35%	-5.09%	-2.97%
EBITDA	-241.38	130.13	315.66	405.52	388.75
EBITDA Margin	-8.16%	3.10%	6.56%	7.21%	7.56%
D&A For EBITDA	34.04	33	51.48	35.7	48.91
EBIT	-275.42	97.13	264.17	369.83	339.84
EBIT Margin	-9.32%	2.32%	5.49%	6.57%	6.61%
Effective Tax Rate	-	46.02%	46.44%	39.43%	35.50%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.